Abstract
Phosphodiesterase 6 (PDE6) is highly concentrated in the retina. It is most abundant in the internal membranes of retinal photoreceptors, where it reduces cytoplasmic levels of cyclic guanosine monophosphate (cGMP) in rod and cone outer segments in response to light. The rod PDE6 holoenzyme comprises α and β catalytic subunits and two identical inhibitory γ subunits. Each catalytic subunit contains three distinct globular domains corresponding to the catalytic domain and two GAF domains (responsible for allosteric cGMP binding). The PDE6 catalytic subunits resemble PDE5 in amino-acid sequence as well as in three-dimensional structure of the catalytic dimer; preference for cGMP over cyclic adenosine monophosphate (cAMP) as a substrate; and the ability to bind cGMP at the regulatory GAF domains. Most PDE5 inhibitors inhibit PDE6 with similar potency, and electroretinogram studies show modest effects of PDE5 inhibitors on visual function—an observation potentially important in designing PDE5-specific therapeutic agents.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Biochemistry and physiology of zebrafish photoreceptors
Pflügers Archiv - European Journal of Physiology Open Access 17 February 2021
-
Effects of phosphodiesterase type 5 inhibitors on choroid and ocular vasculature: a literature review
International Journal of Retina and Vitreous Open Access 06 August 2020
-
Evolution and expression of the phosphodiesterase 6 genes unveils vertebrate novelty to control photosensitivity
BMC Evolutionary Biology Open Access 13 June 2016
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout


References
Rodieck RW . The First Steps in Seeing. Sinauer Associates: Sunderland, MA, 1998 562pp.
Stavenga DG, DeGrip WJ, Pugh Jr EN (eds). Handbook of Biological Physics, Vol. 3: Molecular Mechanisms in Visual Transduction. Elsevier Science, New York, 2002, p 581.
Arshavsky VY, Lamb TD, Pugh Jr EN . G proteins and phototransduction. Annu Rev Physiol 2002; 64: 153–187.
Baehr W, Devlin MJ, Applebury ML . Isolation and characterization of cGMP phosphodiesterase from bovine rod outer segments. J Biol Chem 1979; 254: 11669–11677.
Deterre P et al. cGMP phosphodiesterase of retinal rods is regulated by two inhibitory subunits. Proc Natl Acad Sci USA 1988; 85: 2424–2428.
Gillespie PG, Beavo JA . Characterization of a bovine cone photoreceptor phosphodiesterase purified by cyclic GMP-Sepharose chromatography. J Biol Chem 1988; 263: 8133–8141.
Norton AW et al. Mechanism of transducin activation of frog rod photoreceptor phosphodiesterase: allosteric interactions between the inhibitory γ subunit and the noncatalytic cGMP binding sites. J Biol Chem 2000; 275: 38611–38619.
Mou H, Cote RH . The catalytic and GAF domains of the rod cGMP phosphodiesterase (PDE6) heterodimer are regulated by distinct regions of its inhibitory γ subunit. J Biol Chem 2001; 276: 27527–27534.
Granovsky AE, Natochin M, Artemyev NO . The γ subunit of rod cGMP-phosphodiesterase blocks the enzyme catalytic site. J Biol Chem 1997; 272: 11686–11689.
Kameni Tcheudji JF et al. Molecular organization of bovine rod cGMP-phosphodiesterase 6. J Mol Biol 2001; 310: 781–791.
McAllister-Lucas L et al. The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase deduced from a cDNA clone. J Biol Chem 1993; 268: 22863–22873.
Xu RX et al. Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity. Science 2000; 288: 1822–1825.
Martinez SE et al. The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding. Proc Natl Acad Sci USA 2002; 99: 13260–13265.
Beltman J et al. Characterization of cyclic nucleotide phosphodiesterases with cyclic GMP analogs: topology of the catalytic domains. Mol Pharmacol 1995; 47: 330–339.
Francis SH, Colbran JL, McAllister-Lucas LM, Corbin JD . Zinc interactions and conserved motifs of the cGMP-binding cGMP-specific phosphodiesterase suggest that it is a zinc hydrolase. J Biol Chem 1994; 269: 22477–22480.
He F, Seryshev AB, Cowan CW, Wensel TG . Multiple zinc binding sites in retinal rod cGMP phosphodiesterase, PDE6αβ. J Biol Chem 2000; 275: 20572–20577.
D’Amours MR, Cote RH . Regulation of photoreceptor phosphodiesterase catalysis by its noncatalytic cGMP binding sites. Biochem J 1999; 340: 863–869.
Mou H et al. cGMP binding to noncatalytic sites on mammalian rod photoreceptor phosphodiesterase is regulated by binding of its γ and δ subunits. J Biol Chem 1999; 274: 18813–18820.
Thomas MK, Francis SH, Corbin JD . Characterization of a purified bovine lung cGMP binding cGMP phosphodiesterase. J Biol Chem 1990; 265: 14964–14970.
Corbin JD, Turko IV, Beasley A, Francis SH . Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities. Eur J Biochem 2000; 267: 2760–2767.
Rybalkin SD et al. PDE5 is converted to an activated state upon cGMP binding to the GAF A domain. EMBO J 2003; 22: 469–478.
Lochhead A, Nekrasova E, Arshavsky VY, Pyne NJ . The regulation of the cGMP-binding cGMP phosphodiesterase by proteins that are immunologically related to the γ subunit of the photoreceptor cGMP phosphodiesterase. J Biol Chem 1997; 272: 18397–18403.
Granovsky AE et al. Probing domain functions of chimeric PDE6α/PDE5 cGMP-phosphodiesterase. J Biol Chem 1998; 273: 24485–24490.
Granovsky AE, Artemyev NO . Partial reconstitution of photoreceptor cGMP phosphodiesterase characteristics in cGMP phosphodiesterase-5. J Biol Chem 2001; 276: 21698–21703.
Muradov KG, Granovsky AE, Schey KL, Artemyev NO . Direct interaction of the inhibitory γ-subunit of rod cGMP phosphodiesterase (PDE6) with the PDE6 GAFa domains. Biochemistry 2002; 41: 3884–3890.
Granovsky AE, Artemyev NO . Identification of the γ-subunit interacting residues on photoreceptor cGMP phosphodiesterase, PDE6α′. J Biol Chem 2000; 275: 41258–41262.
Qin N, Pittler SJ, Baehr W . In vitro isoprenylation and membrane association of mouse rod photoreceptor cGMP phosphodiesterase alpha and beta subunits expressed in bacteria. J Biol Chem 1992; 267: 8458–8463.
Anant JS et al. In vivo differential prenylation of retinal cyclic GMP phosphodiesterase catalytic subunits. J Biol Chem 1992; 267: 687–690.
Gillespie PG, Prusti RK, Apel ED, Beavo JA . A soluble form of bovine rod photoreceptor phosphodiesterase has a novel 15 kDa subunit. J Biol Chem 1989; 264: 12187–12193.
Florio SK, Prusti RK, Beavo JA . Solubilization of membrane-bound rod phosphodiesterase by the rod phosphodiesterase recombinant δ subunit. J Biol Chem 1996; 271: 1–12.
Cook TA et al. Binding of the delta subunit to rod phosphodiesterase catalytic subunits requires methylated, prenylated C-termini of the catalytic subunits. Biochemistry 2000; 39: 13516–13523.
Marzesco AM, Galli T, Louvard D, Zahraoui A . The rod cGMP phosphodiesterase delta subunit dissociates the small GTPase Rab13 from membranes. J Biol Chem 1998; 273: 22340–22345.
Li N et al. Characterization of human and mouse rod cGMP phosphodiesterase δ subunit (PDE6D) and chromosomal localization of the human gene. Genomics 1998; 49: 76–82.
Nancy V, Callebaut I, El Marjou A, de Gunzburg J . The δ subunit of retinal rod cGMP phosphodiesterase regulates the membrane association of Ras and Rap GTPases. J Biol Chem 2003; 277: 15076–15084.
Francis SH et al. Phosphorylation of isolated human phosphodiesterase-5 regulatory domain induces an apparent conformational change and increases cGMP binding affinity. J Biol Chem 2002; 277: 47581–47587.
Mullershausen F et al. Rapid nitric oxide-induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme. J Cell Biol 2003; 155: 271–278.
Paglia MJ, Mou H, Cote RH . Regulation of photoreceptor phosphodiesterase (PDE6) by phosphorylation of its inhibitory γ subunit re-evaluated. J Biol Chem 2002; 277: 5017–5023.
Wan KF et al. The inhibitory γ subunit of the Type 6 retinal cyclic guanosine monophosphate phosphodiesterase is a novel intermediate regulating p42/p44 mitogen-activated protein kinase signaling in human embryonic kidney 293 cells. J Biol Chem 2001; 276: 37802–37808.
Ballard SA et al. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 1998; 159: 2164–2171.
Goldstein I et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397–1404.
Luu JK, Chappelow AV, McCulley TJ, Marmor MF . Acute effects of sildenafil on the electroretinogram and multifocal electroretinogram. Am J Ophthalmol 2001; 132: 388–394.
Acknowledgements
Research from the author's laboratory described in this paper was funded by the National Institutes of Health (EY-05798). This is Scientific Contribution Number 2162 from the New Hampshire Agricultural Experiment Station.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cote, R. Characteristics of Photoreceptor PDE (PDE6): similarities and differences to PDE5. Int J Impot Res 16 (Suppl 1), S28–S33 (2004). https://doi.org/10.1038/sj.ijir.3901212
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3901212
Keywords
- cyclic GMP
- 3′,5′-Cyclic-GMP phosphodiesterase
- rods (Retina)
- catalytic domain
- binding sites
This article is cited by
-
Biochemistry and physiology of zebrafish photoreceptors
Pflügers Archiv - European Journal of Physiology (2021)
-
Photoreceptor phosphodiesterase (PDE6): activation and inactivation mechanisms during visual transduction in rods and cones
Pflügers Archiv - European Journal of Physiology (2021)
-
Effects of phosphodiesterase type 5 inhibitors on choroid and ocular vasculature: a literature review
International Journal of Retina and Vitreous (2020)
-
Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson’s Disease?
Molecular Neurobiology (2018)
-
Evolution and expression of the phosphodiesterase 6 genes unveils vertebrate novelty to control photosensitivity
BMC Evolutionary Biology (2016)